SkyePharma names new CFO
This article was originally published in Scrip
SkyePharma has named Andrew Derodra chief financial officer and executive director – effective from the fourth quarter 2013. Mr Derodra joins from UK-based, multinational agribusiness Tate & Lyle, where he has been group vice-president of finance and control since 2011. He succeeds Peter Grant, who was appointed chief executive officer of SkyePharma in January 2012 but retained responsibility for the company's financial affairs.